Amiodarone and postoperative atrial fibrillation

Abstract

New-onset postoperative atrial fibrillation (POAF) develops in 10%-50% of patients after cardiac surgery. In this review, we focus on risk factors associated with POAF and the different pharmacological strategies used for prophylaxis, with special attention to amiodarone. The use of amiodarone will be discussed both as a prophylactic regimen used before and following cardiac surgery, but also as a rhythm control treatment in patients who develop POAF. Finally, we conclude by reviewing gaps in the literature on amiodarone and further studies which could close these gaps.

Keywords

Amiodarone / atrial fibrillation / postoperative / cardiac surgery

References

[1] Maisel WH,Stevenson WG.Atrial fibrillation after cardiac surgery.Ann Intern Med2001;135:1061-73

[2] Dobrev D,Heijman J,Nattel S.Postoperative atrial fibrillation: mechanisms, manifestations and management.Nat Rev Cardiol2019;16:417-36

[3] Mitchell LB,Wyse DG.Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial.JAMA2005;294:3093-100

[4] Auer J,Berent R.Postoperative atrial fibrillation independently predicts prolongation of hospital stay after cardiac surgery.J Cardiovasc Surg2005;46:583-8

[5] Ehrlich MP,Aref T.Atrial fibrillation after cardiac surgery: electrophysiological mechanism and outcome.Ann Thorac Surg2020;109:1765-72

[6] Mariscalco G,Zanobini M.Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score.J Am Heart Assoc2014;3:e000752 PMCID:PMC4187480

[7] Amar D,Leung DH,Kadish AH.Older age is the strongest predictor of postoperative atrial fibrillation.Anesthesiology2002;96:352-6

[8] Yamashita K,Ranjan R,Dosdall DJ.Clinical risk factors for postoperative atrial fibrillation among patients after cardiac surgery.Thorac Cardiovasc Surg2019;67:107-16 PMCID:PMC6359984

[9] Auer J,Berent R,Lamm G.Risk factors of postoperative atrial fibrillation after cardiac surgery.J Card Surg2005;20:425-31

[10] Ad N,Vidne BA.Potential preoperative markers for the risk of developing atrial fibrillation after cardiac surgery.Semin Thorac Cardiovasc Surg1999;11:308-13

[11] Koch CG,Van Wagoner DR,Gillinov AM.Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation.Ann Thorac Surg2006;82:1747-56

[12] Alameddine AK,Alimov VK.Blood transfusion and the risk of atrial fibrillation after cardiac surgery.J Card Surg2014;29:593-9

[13] Fransen E,Dentener M,Buurman W.Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery.Chest1999;116:1233-9

[14] Arsenault KA,Crystal E.Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.Cochrane Database Syst Rev2013;:CD003611 PMCID:PMC7387225

[15] Fuster V,Cannom DS.Task Force on Practice Guidelines, American College of Cardiology/American Heart Association, Committee for Practice Guidelines, European Society of Cardiology, European Heart Rhythm Association, Heart Rhythm SocietyACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).Eur Heart J2006;27:1979-2030

[16] Patti G,Candura D.Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.Circulation2006;114:1455-61

[17] Chen WT,Sood N,Coleman CI.Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis.J Thorac Cardiovasc Surg2010;140:364-72

[18] Healey JS,Crystal E.Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.J Am Coll Cardiol2005;45:1832-9

[19] White CM,Lertsburapa K,Coleman CI.Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.Eur J Cardiothorac Surg2007;31:817-20

[20] El-Haddad MA,Awdallah H.Role of irbesartan in prevention of post-coronary artery bypass graft atrial fibrillation.Am J Cardiovasc Drugs2011;11:277-84

[21] Mekontso-dessap A,Soustelle C,Thébert D.Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function.Ann Thorac Surg2001;71:1428-32

[22] Rodriguez-Gabella T,Muñoz-García AJ.Renin-angiotensin system inhibition following transcatheter aortic valve replacement.J Am Coll Cardiol2019;74:631-41

[23] Kaufman ES,Wang T.Atrial fibrillation follow-up investigation of rhythm management investigatorsRisk of proarrhythmic events in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study: a multivariate analysis.J Am Coll Cardiol2004;44:1276-82

[24] Papiris SA,Kolilekas L,Manali ED.Amiodarone: review of pulmonary effects and toxicity.Drug Saf2010;33:539-58

[25] Vassallo P.Prescribing amiodarone: an evidence-based review of clinical indications.JAMA2007;298:1312-22

[26] Zimetbaum P.Amiodarone for atrial fibrillation.N Engl J Med2007;356:935-41

[27] Hamilton D Sr,Lan H.Amiodarone: a comprehensive guide for clinicians.Am J Cardiovasc Drugs2020;20:549-58

[28] Meng X,Doedée M.Bioavailability of amiodarone tablets administered with and without food in healthy subjects.Am J Cardiol2001;87:432-5

[29] Mitchell LB,Gillis AM.Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects.Circulation1989;80:34-42

[30] Avedissian SN,Joshi MD.Pharmacokinetic disposition of amiodarone when given with an intralipid rescue strategy.Pharmaceutics2021;13:539 PMCID:PMC8069539

[31] Al-Khatib SM,Ackerman MJ.2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the american college of cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm society.Circulation2018;138:e272-391

[32] Lewis JH.Review article: prescribing medications in patients with cirrhosis - a practical guide.Aliment Pharmacol Ther2013;37:1132-56

[33] Fuster V,Cannom DS.American College of Cardiology/American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm SocietyACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.Circulation2006;114:e257-354

[34] Hauser TH,Josephson ME.Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter.Am J Cardiol2004;93:1173-6

[35] Connolly SJ.Evidence-based analysis of amiodarone efficacy and safety.Circulation1999;100:2025-34

[36] Trohman RG,McAninch EA.Amiodarone and thyroid physiology, pathophysiology, diagnosis and management.Trends Cardiovasc Med2019;29:285-95 PMCID:PMC6661016

[37] Pearce EN,Braverman LE.Thyroiditis.N Engl J Med2003;348:2646-55

[38] Goldschlager N,Naccarelli G,Singh B.Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of pacing and electrophysiology.Arch Intern Med2000;160:1741-8

[39] Wolkove N.Amiodarone pulmonary toxicity.Can Respir J2009;16:43-8 PMCID:PMC2687560

[40] Olshansky B,Rubin A.NHLBI AFFIRM InvestigatorsUse of amiodarone for atrial fibrillation in patients with preexisting pulmonary disease in the AFFIRM study.Am J Cardiol2005;95:404-5

[41] Madrid AH,Rebollo JM.Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.Circulation2002;106:331-6

[42] Nachimuthu S,Schussler JM.Drug-induced QT interval prolongation: mechanisms and clinical management.Ther Adv Drug Saf2012;3:241-53 PMCID:PMC4110870

[43] Daoud EG,Man KC.Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery.N Engl J Med1997;337:1785-91

[44] Giri S,Dunn AB.Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial.Lancet2001;357:830-6

[45] Budeus M,Perings S.Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study.Eur Heart J2006;27:1584-91

[46] Guarnieri T,Gottlieb SO,Lowry DR.Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the amiodarone reduction in coronary heart (ARCH) trial.J Am Coll Cardiol1999;34:343-7

[47] Beaulieu Y,Couture P.Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery.Anesthesiology2010;112:128-37

[48] Tokmakoglu H.Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation.Eur J Cardiothorac Surg2002;21:401-5

[49] Zebis LR,Thomsen HF.Practical regimen for amiodarone use in preventing postoperative atrial fibrillation.Ann Thorac Surg2007;83:1326-31

[50] Yagdi T,Ayik F.Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting.J Thorac Cardiovasc Surg2003;125:1420-5

[51] Gillinov AM,Moskowitz AJ.CTSNRate control versus rhythm control for atrial fibrillation after cardiac surgery.N Engl J Med2016;374:1911-21 PMCID:PMC4908812

[52] Lewicki Ł,Rogowski J.Atrial fibrillation following off-pump versus on-pump coronary artery bypass grafting: incidence and risk factors.Cardiol J2016;23:518-23

[53] Almassi GH,Collins JF,Zenati MA.Predictors and impact of postoperative atrial fibrillation on patients' outcomes: a report from the Randomized On Versus Off Bypass trial.J Thorac Cardiovasc Surg2012;143:93-102

[54] Gough WB,Barreca P.Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs.J Cardiovasc Pharmacol1982;4:375-80

[55] Saul JP.Is it time to tell the emperor he has no clothes?.Circ Arrhythm Electrophysiol2010;3:115-7

[56] Lindquist DE,Heidel E,Yates JR.Evaluation of the hemodynamic effects of intravenous amiodarone formulations during the maintenance phase infusion.Ann Pharmacother2015;49:1317-21

[57] Cushing DJ,Cooper WD,Gralinski MR.PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects.Eur J Pharmacol2009;607:167-72

[58] Ad N,Patel J.The impact of a multidisciplinary blood conservation protocol on patient outcomes and cost after cardiac surgery.J Thorac Cardiovasc Surg2017;153:597-605.e1